Summary by Futu AI
Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. (VRTX), completed a gift transaction of 4,600 shares of common stock on June 5, 2024. The shares were disposed of at no cost, as it was a bona fide gift. Following the transaction, Sachdev's direct holdings in the company remain at 57,290 shares. The shares disposed of were held in trust, indicating an indirect form of ownership. The transaction has been completed, and Sachdev now indirectly holds 882 shares after the event.